Trials / Completed
CompletedNCT05047341
A Study of Human Substance Balance and Biotransformation of [14C]SHR0302
A Clinical Trial of the Absorption, Metabolism and Excretion of [14C]SHR0302 in Healthy Chinese Adult Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to evaluate the absorption, metabolism and excretion of \[14C\]SHR0302 in healthy Chinese adult male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR0302、[14C]SHR0302 | 8 mg SHR0302/ 80 µCi \[14C\]SHR0302, once, D1 |
Timeline
- Start date
- 2021-09-07
- Primary completion
- 2021-09-19
- Completion
- 2022-06-08
- First posted
- 2021-09-17
- Last updated
- 2022-07-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05047341. Inclusion in this directory is not an endorsement.